Clinical Trial Update: Efficacy of a Triptan in the Treatment of Hostility and Aggression Among Convicts With a Psychiatric Treatment Order [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy of a triptan to reduce hostility and aggression in convicts under psychiatric treatment orders was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antisocial Personality Disorder
• Impulse Control Disorders
• Intermittent Explosive Disorder
• Psychotic Disorders

Drugs mentioned

• Triptan (class) (triptan class)

Snippet

Sponsor: UMC Utrecht | Conditions: Psychotic Disorders, Antisocial Personality Disorder | Phase 4 | Status: TERMINATED